Tumor markers produced by cancer cells or normal cells in response to cancer such as prostate-specific antigen (PSA) for prostate cancer or carcinoembryonic antigen (CEA) for colorectal cancer can indicate the presence of metastasis or monitor treatment response (108). This evidence concerns the gene CEACAM5 and prostate carcinoma.